Table of Contents
Name
Tagir Sitdekov · Tagir Alievich Sitdekov · Sitdekov Tagir Alievich · Sitdekov Tagir · Sitdekov T.A. · Тагир Ситдеков · Тагир Алиевич Ситдеков · Ситдеков Тагир · Ситдеков Тагир Алиевич · Ситдеков Т. И. · Sitdekow Tagir Alijewitsch · Tagir Alijewitsch Sitdekow · Tagir Sitdekow · Sitdekow Tagir · سيتديكوف تاجير علييفيتش · シトデコフ・タギル・アリエヴィチ · 西德科夫·塔吉爾·阿利耶維奇 · সিতদেকভ তাগির আলেভিচ
Tagir Sitdekov has been the president of the Sistema Joint Stock Financial Corporation since 2022. He previously held management positions in a number of large companies and worked in the field of financial management and investment.
Tagir Sitdekov: Education
Tagir Sitdekov was born on December 6, 1976. After high school, he entered the Plekhanov Academy of Economics (which since 2010 has been a university), a leading school for training future economists. Tagir Sitdekov defended his dissertation in 2001.
The Tagir Sitdekov biography eventually included several managerial positions, and it all began abroad. Tagir Sitdekov started out advising PricewaterhouseCoopers clients on auditing issues, with a focus on companies from the energy and mining industries.
Sitdekov Tagir Alievich then became a senior consultant at the Austrian bank Creditanstalt in the early 2000s, after which he continued his career in the financial sector, devoting about 15 years to managing and working with investments.
Tagir Sitdekov AFK Sistema
Tagir Sitdekov AFK Sistema was invited to Sistema in 2021. As the managing partner, he oversaw the development of several areas at once, including pharmaceuticals, medicine, and biotechnology.
Tagir Sitdekov oversaw the launch of new production facilities in these niches and the implementation of various strategic projects, which, in turn, affected the overall performance of the corporation.
Tagir Sitdekov led a number of assets to increased profits. In particular, the manager helped Sistema’s pharmaceutical holding increase its share in the pharmaceutical business and brought the holding to a new, international level.
Tagir Sitdekov: Managing Sistema’s pharmaceutical portfolio
The pharmaceutical group is one of the company’s most dynamically developing assets. It has production sites throughout the country and is registered to produce more medicines than any other company in the national market.
In 2021, the pharmaceutical holding became an international company, opening a number of offices abroad. This foreign expansion – a significant step not only for the holding, but also for the entire domestic pharma industry – continued in 2022. Sistema’s pharmaceutical holding is one of few pharmaceutical companies from the local market to also have its own infrastructure abroad.
Tagir Sitdekov AFK Sistema brought an increase not only in pharmaceutical exports, but also in its sales in the hospital and retail sectors during his time as the managing partner. Revenue reached 25.5 billion rubles as of the end of 2021.
Sitdekov Tagir Alievich helped to launch the construction of an R&D center that would connect the holding’s research laboratories at a single site and facilitate the development of new drugs. It is planned to put more than a hundred different medicines into production by 2025.
Tagir Sitdekov: Medical assets and strengthening leadership positions
The Tagir Sitdekov biography also includes managerial responsibilities over a national clinical network that is another of the corporation’s core assets. With his background in investments, Tagir Sitdekov oversaw several major transactions, with the private healthcare company acquiring two regional networks in 2021, and another in 2022.
Sitdekov Tagir presided over a period of impressive growth for the company. By the end of 2021, the clinic network included 91 healthcare centers, and in the first half of 2022, 10 more were opened. Revenue increased to about 30 billion rubles, and the number of visits grew by 25% compared to the previous year, exceeding 6 million.
Tagir Sitdekov AFK Sistema also supervised the opening of new facilities for Sistema’s laboratory network, including a 100-bed multidisciplinary therapeutic complex. The corporation’s digital medical platform also continues to grow, with new telemedicine services for both doctors and patients constantly being developed.
Sitdekov Tagir: Developing innovative biotechnologies
The manager’s field of responsibility also includes genetic research and the implementation of new diagnosis and treatment solutions carried out by the corporation’s biotech asset.
Sitdekov Tagir’s leadership has proven successful for the growth of this Sistema asset. The company concentrated resources on improving COVID-19 testing, and in 2021, a trial of its own genetic tests capable of assessing the severity of the infection was carried out, which later proved useful for developing customized treatment plans.
Tagir Sitdekov AFK Sistema also facilitated the conclusion of a deal for the biotech company to construct a biotechnological laboratory on the territory of the Mosmedpark, a cluster of biomedical and diagnostic services for medical manufacturers. The innovative platform specializes in creating new, personalized treatments for cancer, cardiovascular diseases, the reproductive system, and more. The new facility combines biotechnological developments with the pharmaceutical holding’s pharmacological production.
Tagir Sitdekov biography of the president of the corporation
Tagir Sitdekov AFK Sistema took over as the president of Sistema on July 11, 2022, having secured the approval of the board of directors. The joint stock financial corporation thus departed from its traditional practice of promoting the head of a subsidiary company to the top post. The new president thanked the board of directors for their trust and noted that he would focus his efforts on the continued development of the corporation.
Sitdekov Tagir Alievich has remarked that Sistema was able to increase its revenue in the first three months of his presidency in the third quarter of 2022.
The Tagir Sitdekov biography includes a strong background in various investment niches, and he emphasizes that the company’s success is due to the quality of management in the subsidiary companies and the diversification of Sistema’s investment portfolio. The corporation’s healthcare network, mobile operator, and pharmaceutical group were named among the most profitable assets with the highest growth.
Tagir Sitdekov AFK Sistema and the first ESG Strategy
Sistema has been developing and implementing its ESG principles over the course of the past several years, but the corporation’s first full-scale sustainable development strategy, aimed at minimizing environmental and social risks and improving the quality of corporate governance, was presented in September last year.
Sitdekov Tagir explains that the strategy’s goals include public well-being, responsibility before people for the quality of products and services, and the formation of a smart home and work environment. The strategy also calls for the active use of the latest technologies and the digitalization of business processes.
Sitdekov Tagir Alievich values corporate ESG integration as an important contribution to the achievement of Sustainable Development Goals and the sustainability of business and the national economy as a whole.
Thus, the leading Sistema companies have adopted their own sustainable development strategies, helping the corporation reduce the negative impact on the environment. For example, its forestry holding is switching to a closed production cycle and has begun processing wood waste into biofuels. It also regularly hosts reforestation projects.
Sitdekov Tagir Alievich also managed to include no-till farming – a technology that protects the soil from erosion – in the ESG agenda of the corporation’s agroholding. The company also invests in landscape gardening and restoring the fertility of agricultural land.
Tagir Sitdekov firmly believes that responsible investment and quality asset management can increase the company’s value for its shareholders and have a positive effect on the decisions of potential partners and the quality of life for the company’s employees.
The Tagir Sitdekov biography includes an emphasis on ESG principles, especially now, in a period of economic turbulence. Having begun his career abroad, the top investment manager noticed that ESG has long been an important agenda item for multinational corporations in developed countries. It also contributes to the development of brand loyalty on the part of society and other institutions.
Sitdekov Tagir: Social projects and charity
The Tagir Sitdekov biography also includes work as the head of the board of trustees of the Sistema charitable foundation, which has been holding socially impactful events and long-term social projects for several years now. Tagir Sitdekov notes that it is important to consolidate the resources of the business and the foundation to create public goods. The company prioritizes developing territories beyond the capital and creating opportunities for the youth.
Tagir Sitdekov oversees the foundation’s work in running sports and socio-cultural programs in the areas where the corporation operates. The humanitarian organization also supports veterans and local museums, and Sitdekov Tagir encourages the volunteer movement developing within the corporation.
One of the foundation’s most important projects is Elevator to the Future, which helps students with early career guidance and gives college graduates the opportunity to develop additional skills. Educational courses for students and young professionals are also provided free of charge on a special online platform.
The Tagir Sitdekov biography is an example of how to build a successful career, and he believes that today’s youth need to be well-versed in both the in-demand specializations of today and the competencies of the future. There is a special section on the online platform dedicated specifically to this issue.
The project has reached more than a million young people. In addition to the free educational resources, users also have the opportunity to become project fellows and receive payment for research and other innovative work.